Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Katharine Yao

Concepts (252)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Mastectomy
45
2022
217
15.330
Why?
Breast Neoplasms
80
2022
2699
15.220
Why?
Carcinoma, Ductal, Breast
21
2019
151
7.550
Why?
Carcinoma, Lobular
18
2019
78
6.920
Why?
Mastectomy, Segmental
15
2022
88
4.060
Why?
Neoadjuvant Therapy
8
2019
265
3.310
Why?
Neoplasm Staging
25
2019
1858
2.930
Why?
Mammaplasty
9
2022
94
2.740
Why?
Quality Indicators, Health Care
5
2021
130
2.380
Why?
Lymph Node Excision
10
2021
197
2.300
Why?
Sentinel Lymph Node Biopsy
12
2021
55
2.220
Why?
Cancer Care Facilities
3
2020
26
2.170
Why?
Radiation Oncology
3
2021
117
2.150
Why?
Databases, Factual
18
2018
756
2.090
Why?
Accreditation
3
2019
51
2.060
Why?
Prognosis
25
2020
3522
2.060
Why?
Receptors, Estrogen
9
2019
375
2.040
Why?
Middle Aged
62
2022
23948
2.000
Why?
Female
83
2022
42244
1.960
Why?
Practice Guidelines as Topic
7
2019
1030
1.880
Why?
Carcinoma, Intraductal, Noninfiltrating
6
2016
106
1.840
Why?
Guideline Adherence
4
2018
215
1.810
Why?
Neoplasm Recurrence, Local
9
2020
1156
1.800
Why?
Follow-Up Studies
21
2020
3553
1.750
Why?
Aged, 80 and over
33
2018
6195
1.710
Why?
Chemotherapy, Adjuvant
8
2019
441
1.700
Why?
Aged
48
2021
17394
1.680
Why?
Radiotherapy, Adjuvant
9
2021
284
1.670
Why?
Mastectomy, Subcutaneous
2
2022
7
1.580
Why?
Nipples
6
2022
35
1.530
Why?
Humans
90
2022
79512
1.530
Why?
Receptor, erbB-2
5
2019
182
1.440
Why?
Thoracic Wall
2
2018
22
1.430
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2019
2277
1.340
Why?
Lymph Nodes
4
2018
507
1.340
Why?
Neoplasm Invasiveness
9
2020
512
1.240
Why?
Adult
42
2021
24525
1.240
Why?
Decision Support Techniques
2
2019
154
1.240
Why?
United States
26
2022
6050
1.240
Why?
Combined Modality Therapy
8
2021
1602
1.190
Why?
Decision Making
4
2019
595
1.180
Why?
Retrospective Studies
23
2020
7386
1.140
Why?
Breast
6
2021
265
1.130
Why?
Axilla
11
2021
92
1.120
Why?
Receptors, Progesterone
6
2019
163
1.110
Why?
Neoplasms, Second Primary
3
2017
242
1.100
Why?
Survival Rate
12
2018
1809
1.070
Why?
Carcinoma
2
2017
412
0.970
Why?
Brachytherapy
2
2014
115
0.960
Why?
Breast Neoplasms, Male
1
2022
28
0.940
Why?
Organ Sparing Treatments
2
2019
34
0.920
Why?
Attitude of Health Personnel
2
2018
625
0.890
Why?
Neoplasm Grading
10
2018
319
0.870
Why?
Quality of Health Care
3
2018
360
0.820
Why?
Burnout, Professional
1
2021
78
0.770
Why?
Healthcare Disparities
2
2015
325
0.760
Why?
Lymphatic Metastasis
7
2018
465
0.750
Why?
Age Factors
9
2018
1797
0.740
Why?
Antineoplastic Agents, Hormonal
3
2017
146
0.730
Why?
Stereotaxic Techniques
1
2019
69
0.720
Why?
Patient Satisfaction
4
2016
422
0.710
Why?
Patient Selection
6
2019
662
0.700
Why?
Reoperation
5
2015
562
0.700
Why?
Consensus
2
2016
288
0.690
Why?
Coronavirus Infections
2
2020
283
0.690
Why?
Patient Care
1
2019
88
0.690
Why?
Pneumonia, Viral
2
2020
302
0.690
Why?
Patient Transfer
1
2018
90
0.680
Why?
Genes, BRCA2
3
2016
147
0.670
Why?
Radiography, Interventional
1
2019
148
0.670
Why?
Genes, BRCA1
3
2016
185
0.660
Why?
Young Adult
12
2021
5701
0.650
Why?
Patient Acceptance of Health Care
2
2017
217
0.650
Why?
Radiotherapy, Conformal
1
2017
87
0.640
Why?
Patient Preference
4
2019
103
0.620
Why?
Logistic Models
7
2017
1113
0.620
Why?
Postoperative Complications
7
2016
2067
0.610
Why?
Societies, Medical
2
2019
565
0.590
Why?
Quality of Life
4
2019
1342
0.570
Why?
Health Knowledge, Attitudes, Practice
2
2019
488
0.560
Why?
Prospective Studies
8
2022
3870
0.560
Why?
Estrogen Receptor alpha
2
2013
138
0.540
Why?
Patient Education as Topic
1
2016
340
0.500
Why?
Cross-Sectional Studies
4
2021
1367
0.480
Why?
Length of Stay
3
2015
647
0.470
Why?
Melanoma
2
2009
426
0.470
Why?
Receptors, Notch
2
2010
116
0.470
Why?
Skin Neoplasms
2
2009
510
0.450
Why?
Radiotherapy, Intensity-Modulated
1
2013
181
0.450
Why?
Registries
1
2014
648
0.430
Why?
Patient Readmission
1
2014
287
0.410
Why?
Receptor, Notch1
2
2010
80
0.410
Why?
Workload
2
2022
125
0.410
Why?
Operating Rooms
2
2022
118
0.410
Why?
Adolescent
7
2021
8657
0.390
Why?
Gelatin Sponge, Absorbable
1
2008
3
0.370
Why?
Socioeconomic Factors
3
2016
535
0.350
Why?
Breast Diseases
1
2008
96
0.350
Why?
Quality Control
2
2019
112
0.340
Why?
Breast Implantation
3
2016
10
0.330
Why?
Calcinosis
1
2008
232
0.320
Why?
Proto-Oncogene Proteins
2
2010
642
0.320
Why?
Pilot Projects
3
2019
796
0.310
Why?
SEER Program
3
2017
179
0.310
Why?
Risk Factors
6
2019
5099
0.310
Why?
Randomized Controlled Trials as Topic
3
2017
803
0.300
Why?
Multivariate Analysis
4
2018
962
0.290
Why?
Magnetic Resonance Imaging
1
2017
3069
0.280
Why?
Health Care Surveys
2
2018
275
0.280
Why?
Risk Assessment
4
2020
2158
0.280
Why?
Proportional Hazards Models
3
2017
823
0.280
Why?
Referral and Consultation
2
2019
304
0.270
Why?
Biopsy
3
2014
1117
0.250
Why?
Time Factors
5
2016
5143
0.240
Why?
Radiotherapy Dosage
2
2014
480
0.230
Why?
Cohort Studies
4
2018
2561
0.210
Why?
Pandemics
3
2022
555
0.210
Why?
Male
8
2022
39419
0.200
Why?
Gene Expression Profiling
2
2019
1322
0.200
Why?
Mammography
2
2017
451
0.200
Why?
Personnel Selection
1
2020
52
0.190
Why?
Longitudinal Studies
2
2020
947
0.190
Why?
Specialties, Surgical
1
2020
59
0.190
Why?
Health Resources
1
2020
73
0.190
Why?
Fear
1
2019
66
0.190
Why?
Triage
1
2020
97
0.190
Why?
Body Image
1
2019
79
0.190
Why?
Uterine Cervical Neoplasms
1
2022
248
0.190
Why?
Treatment Outcome
5
2018
7469
0.190
Why?
Fellowships and Scholarships
1
2020
94
0.190
Why?
Breast Implants
2
2016
20
0.190
Why?
Interviews as Topic
1
2020
314
0.180
Why?
Anxiety
1
2021
250
0.180
Why?
User-Computer Interface
1
2020
184
0.180
Why?
Video Recording
1
2019
184
0.180
Why?
Neoplasm Micrometastasis
1
2018
4
0.180
Why?
Databases as Topic
1
2018
89
0.180
Why?
Emotions
1
2021
303
0.170
Why?
Telemedicine
1
2020
138
0.170
Why?
Patient Participation
1
2019
194
0.170
Why?
Patient Compliance
1
2018
220
0.160
Why?
Heterozygote
2
2016
352
0.160
Why?
Choice Behavior
1
2018
155
0.160
Why?
Sleep
1
2021
411
0.160
Why?
Odds Ratio
1
2018
647
0.160
Why?
Surgical Wound Infection
2
2015
171
0.160
Why?
Ultrasonography, Mammary
1
2017
82
0.150
Why?
Disease Management
1
2018
323
0.150
Why?
Esthetics
1
2016
49
0.150
Why?
Watchful Waiting
1
2016
48
0.150
Why?
Illinois
1
2017
446
0.150
Why?
Radiotherapy Planning, Computer-Assisted
1
2017
190
0.150
Why?
Comprehension
1
2016
67
0.150
Why?
Molecular Typing
1
2015
15
0.150
Why?
Europe
1
2016
293
0.150
Why?
Physicians
2
2019
588
0.150
Why?
Pharyngectomy
1
2015
8
0.140
Why?
Remission Induction
1
2017
701
0.140
Why?
Patients
1
2016
88
0.140
Why?
Population Surveillance
1
2016
218
0.140
Why?
Counseling
1
2016
135
0.140
Why?
Immunohistochemistry
2
2010
1722
0.140
Why?
Colorectal Neoplasms
1
2022
842
0.140
Why?
Carcinoma in Situ
1
2015
52
0.140
Why?
Selection Bias
1
2014
36
0.140
Why?
Linear Models
1
2015
401
0.130
Why?
Chemoradiotherapy
1
2017
292
0.130
Why?
Case-Control Studies
2
2018
1722
0.130
Why?
Neoplasm Metastasis
1
2018
1032
0.130
Why?
Incidence
2
2017
1528
0.130
Why?
Cost-Benefit Analysis
1
2016
418
0.130
Why?
Adipokines
1
2013
18
0.130
Why?
Insurance, Health
1
2014
145
0.130
Why?
Oropharyngeal Neoplasms
1
2015
120
0.120
Why?
Kaplan-Meier Estimate
1
2015
845
0.120
Why?
Fatty Acids
1
2013
123
0.120
Why?
Venous Thromboembolism
1
2015
115
0.120
Why?
Surgical Flaps
1
2015
246
0.120
Why?
Adipose Tissue
1
2013
234
0.110
Why?
Health Services Accessibility
1
2014
367
0.110
Why?
Reproducibility of Results
1
2017
2570
0.100
Why?
Head and Neck Neoplasms
1
2017
997
0.100
Why?
Models, Biological
1
2018
1724
0.100
Why?
Gene Expression Regulation, Neoplastic
1
2015
1163
0.100
Why?
Lung Neoplasms
1
2022
2112
0.100
Why?
Calcium-Binding Proteins
1
2010
111
0.100
Why?
Intercellular Signaling Peptides and Proteins
1
2010
176
0.090
Why?
African Americans
2
2017
1076
0.090
Why?
Receptor Cross-Talk
1
2008
32
0.090
Why?
False Positive Reactions
1
2008
217
0.090
Why?
Hemostatics
1
2008
52
0.090
Why?
Neoplastic Cells, Circulating
1
2008
63
0.090
Why?
Interferon-alpha
1
2009
234
0.090
Why?
Carcinoma, Squamous Cell
1
2015
1025
0.090
Why?
Biopsy, Needle
1
2008
233
0.090
Why?
Hyperplasia
1
2008
141
0.090
Why?
Chi-Square Distribution
1
2008
359
0.080
Why?
Cancer Vaccines
1
2009
152
0.080
Why?
Immunologic Factors
1
2009
157
0.080
Why?
Drug Delivery Systems
1
2008
172
0.080
Why?
Obesity
1
2013
907
0.080
Why?
RNA, Messenger
1
2012
1920
0.080
Why?
Analysis of Variance
1
2008
899
0.080
Why?
Disease-Free Survival
2
2011
1175
0.070
Why?
Neoplasms
1
2018
2618
0.060
Why?
Sensitivity and Specificity
1
2008
1937
0.060
Why?
Membrane Proteins
1
2010
1161
0.060
Why?
Predictive Value of Tests
1
2008
1618
0.060
Why?
Mutation
1
2014
3745
0.060
Why?
Immunoenzyme Techniques
2
2013
301
0.060
Why?
Organizational Innovation
1
2020
35
0.050
Why?
Tumor Cells, Cultured
2
2013
1039
0.050
Why?
Fees and Charges
1
2018
13
0.050
Why?
Hospital Charges
1
2018
28
0.050
Why?
Program Evaluation
1
2020
285
0.040
Why?
Quality Improvement
1
2022
359
0.040
Why?
Early Detection of Cancer
1
2022
337
0.040
Why?
Propensity Score
1
2018
133
0.040
Why?
Urologic Surgical Procedures
1
2018
99
0.040
Why?
Area Under Curve
1
2018
334
0.040
Why?
Postoperative Care
1
2017
206
0.040
Why?
Tumor Burden
1
2017
273
0.040
Why?
Chicago
1
2020
1327
0.040
Why?
ROC Curve
1
2018
734
0.040
Why?
Cell Proliferation
2
2013
1540
0.030
Why?
Prostatectomy
1
2018
436
0.030
Why?
Self Report
1
2016
269
0.030
Why?
Communication
1
2018
398
0.030
Why?
Prosthesis Failure
1
2015
112
0.030
Why?
Blood Transfusion
1
2015
147
0.030
Why?
Serpins
1
2013
26
0.030
Why?
Lipase
1
2013
21
0.030
Why?
Transplantation, Autologous
1
2015
316
0.030
Why?
Nerve Growth Factors
1
2013
60
0.030
Why?
Leptin
1
2013
98
0.030
Why?
Risk
1
2015
669
0.030
Why?
Physician-Patient Relations
1
2018
576
0.030
Why?
Ki-67 Antigen
1
2012
57
0.030
Why?
Microarray Analysis
1
2012
93
0.030
Why?
Eye Proteins
1
2013
122
0.030
Why?
Sepsis
1
2015
264
0.030
Why?
In Situ Hybridization, Fluorescence
1
2012
349
0.030
Why?
Comorbidity
1
2015
907
0.030
Why?
Body Mass Index
1
2013
740
0.020
Why?
Neoplasms, Hormone-Dependent
1
2008
38
0.020
Why?
Estradiol
1
2008
246
0.020
Why?
Xenograft Model Antitumor Assays
1
2008
441
0.020
Why?
Mice, Nude
1
2008
764
0.020
Why?
RNA, Small Interfering
1
2008
537
0.020
Why?
Mice, Inbred BALB C
1
2008
1038
0.020
Why?
Mice
1
2008
10710
0.010
Why?
Animals
1
2008
25594
0.010
Why?
Yao's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_